Literature DB >> 7756176

Role of cell type-specific promoters in the developmental regulation of T1, an interleukin 1 receptor homologue.

E Thomassen1, G Kothny, S Haas, J Danescu, L Hültner, P Dörmer, A K Werenskiold.   

Abstract

Murine T1, an orphan receptor related to interleukin 1 receptors, exhibits a bimodal expression in mouse development. The molecular analysis of cultured cell lines now reveals the contribution of alternate promoters of the T1 gene to its differential expression. In nonhemopoietic cell types, where T1 synthesis in vivo is restricted to organogenesis and neoplasia, a recently characterized AP-1-dependent promoter directs a proliferation-associated expression of the gene. In hemopoietic cells, which express the T1 receptor throughout ontogenesis in vivo, T1 gene activity is driven by a novel serum factor-independent, constitutive promoter. The tissue-specific use of constitutive versus growth factor-dependent alternate promoters thus directs the permanent activity of the T1 gene in hemopoietic tissue versus the developmentally restricted expression of the gene in nonhemopoietic tissues in vivo.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7756176

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  7 in total

Review 1.  Implications for Interleukin-33 in solid organ transplantation.

Authors:  Quan Liu; Hēth R Turnquist
Journal:  Cytokine       Date:  2013-03-27       Impact factor: 3.861

2.  Soluble ST2 links inflammation to outcome after subarachnoid hemorrhage.

Authors:  Matthew B Bevers; Zoe Wolcott; Søren Bache; Christina Hansen; Cristina Sastre; Ravi Mylvaganam; Matthew J Koch; Aman B Patel; Kirsten Møller; W Taylor Kimberly
Journal:  Ann Neurol       Date:  2019-07-30       Impact factor: 10.422

Review 3.  Disease-associated functions of IL-33: the new kid in the IL-1 family.

Authors:  Foo Y Liew; Nick I Pitman; Iain B McInnes
Journal:  Nat Rev Immunol       Date:  2010-01-18       Impact factor: 53.106

Review 4.  The IL-33/ST2 pathway: therapeutic target and novel biomarker.

Authors:  Rahul Kakkar; Richard T Lee
Journal:  Nat Rev Drug Discov       Date:  2008-10       Impact factor: 84.694

5.  Elevated ST2 Distinguishes Incidences of Pediatric Heart and Small Bowel Transplant Rejection.

Authors:  L R Mathews; J M Lott; K Isse; A Lesniak; D Landsittel; A J Demetris; Y Sun; D F Mercer; S A Webber; A Zeevi; R T Fischer; B Feingold; H R Turnquist
Journal:  Am J Transplant       Date:  2015-12-11       Impact factor: 8.086

Review 6.  The ST2/IL-33 Axis in Immune Cells during Inflammatory Diseases.

Authors:  Brad Griesenauer; Sophie Paczesny
Journal:  Front Immunol       Date:  2017-04-24       Impact factor: 7.561

7.  Alteration of the IL-33-sST2 pathway in hypertensive patients and a mouse model.

Authors:  Xiaoyun Yin; Huajun Cao; Yingjie Wei; Hui-Hua Li
Journal:  Hypertens Res       Date:  2019-06-24       Impact factor: 3.872

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.